BD Solutions for Efficient Management of HAIs

Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality around the world. An estimated 6 million healthcare-associated infections occur each year across the U.S., Europe and Japan alone. Beyond the human toll, HAIs poses an enormous financial burden to healthcare systems worldwide. BD is committed to applying its expertise, resources and technologies toward the prevention of healthcare-associated infections worldwide. Helping to prevent HAIs perfectly aligns with BD's core purpose of "helping all people live healthy lives".

BD Diagnostics offers you a comprehensive range of assays (Screening/Diagnostic; Molecular/ Chromogenic/ Conventional) to identify HAI causing organisms in the most efficient way corresponding to your unique and individual setting.

For the latest information on BD's strategy concerning HAIs, please sign up at BD HAIs Web site www.bd.com/HAIs.



Products & Services

1 - Preventing the spread of drug-resistant bacteria : Rapid molecular assays »
[divider line]
2 - Reliable detection, identification and screening with BD BBL™ CHROMagar™ Products.»
[divider line]
3 - Accurate Diagnosis for Appropriate Antibiotic Usage »
[divider line]
4 - Efficient communication tools for laboratory and hospital »
[divider line]



BD is proud to support Infection Preventionists worldwide as a 2009 APIC Strategic Partner
BD is proud to support Infection Preventionists worldwide as a 2009 APIC Strategic Partner
Learn more »

[spacer image]

BD is a member of the Strategic Partnership program of the International Federation of Infection Control
BD is a member of the Strategic Partnership program of the International Federation of Infection Control
BD is a member of the Strategic Partnership program of the International Federation of Infection Control
Learn more »




Learn more about...

[bullet] Literature References »

[bullet] BD Adds Surveillance Capability to Infectious Disease Portfolio » »

 
HAI Archive»